Compass Therapeutics Inc (CMPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Gross Profit | 16,080 | 13,430 | 15,300 | 12,710 | 14,210 |
| Operating Expenses | 720 | 570 | 640 | 620 | 520 |
| Operating Income | -720 | -570 | -640 | -620 | -520 |
| Pre-tax Income | -720 | -570 | -640 | -620 | -520 |
| Net Income Continuous | -720 | -570 | -640 | -620 | -520 |
| Net Income | $-720 | $-570 | $-640 | $-620 | $-520 |
| EBITDA(a) | $-210 | $-240 | $-20 | $-270 | $-220 |